Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32377 total
AMZN closes the week at $259.45, down nearly 5% — yet the options market is the least defensive it has been all year. The clearest tension this week is between the price action and how call buyers are behaving. The…
Alexandria Real Estate Equities enters the back half of August with its sharpest options skew in months, a stock price near its lowest level in the recent slide, and a founder quietly buying into the weakness — a setup…
Agnico Eagle Mines enters the back half of August carrying one of the more striking monthly performances in the gold mining space — up 36% over the past 30 days to $186.94 — yet the stock slipped nearly 1% on Tuesday…
AMD has given back ground a second time — dropping 4.3% Tuesday to close at $484.39 — yet the analyst community that responded to early-August earnings with a wave of target upgrades has not blinked. The most striking…
ADBE enters its September 10 earnings date with the stock 27% lower year-to-date, yet up 11% over the past month — a recovery that looks more like a relief rally than a re-rating, given how divided the Street remains…
ABT enters the final stretch of summer with a rare alignment of signals: a fresh analyst upgrade, a stock up 12% over the past month, and options traders at their most bullish in a year. The most telling move of the…
Aflac heads into the back half of August with a fresh bearish initiation pulling against a broader wave of target-price upgrades — a rare moment of genuine analyst disagreement for a stock that usually attracts little…
Iovance Biotherapeutics is now up 41% in a single month and the short book, while trimming at the margins for a third consecutive week, remains one of the heaviest in biotech — a standoff that continues to define the…
CMHC enters the week under genuine pressure, down 10% over the past month and 7% in the past week alone, with valuation multiples compressing and earnings momentum that has yet to translate into price recovery. The…
XTB arrives at its August 28 earnings date on a striking run — up 27% in the past month to PLN 166.46, with shorts almost entirely absent and the borrow market looser than it has been all year. The lending picture is…
AST SpaceMobile enters the week with a fresh contradiction: bears are still covering, but the borrow market has snapped back to near-zero availability — suggesting whatever supply entered the pool after earnings has…
Tuesday's earnings wave dominated Tuesday's market conversation. TGT and LOW led the morning slate. WMT looms largest this week — reporting Thursday with a $900bn market cap and 25 consecutive quarters of revenue…
Energy stocks dominated analyst desks Tuesday. Diamondback Energy took the sharpest hit — a fresh downgrade pushed its consensus lower. The Permian Basin driller carries a $58.8 billion market cap. Short interest sits…
Insider filings this week reveal two standout stories moving in opposite directions — a billionaire buying into waste management and a hedge fund dumping AI infrastructure stock. Bill Gates filed $263M worth of…
Short sellers made fresh moves this week across several high-profile names. Reddit saw the sharpest increase among liquid stocks. SI % FF jumped from 13.7% to 17.9% in just seven days — a gain of 4.2 percentage…
The single biggest story this week: investors pulled $2.5B out of Information Technology ETFs. That makes Tech the hardest-hit sector over seven days. It is a sharp reversal from the 3-month picture, where Tech…
Today's session delivers a flood of consumer data. LOW CEO flagged "pressure in discretionary DIY spending" in results this morning. That warning lands on a day when TGT, TJX, ADI, and PGR also report. The home…
Options markets are flashing mixed signals on August 19. Semiconductors dominate both the bullish and bearish sides of the tape. SanDisk tops the week's positive options bets. The stock is up 585% year-to-date. That…
Cantor Fitzgerald slashed its price target on CRWD from $725 to $250. The firm kept its Buy rating. That is a 66% cut — one of the sharpest target reductions seen on a mega-cap cybersecurity name. CrowdStrike carries a…
Two of this week's biggest insider stories sit at opposite ends of the ledger. Aehr Test Systems saw a coordinated exit. Six insiders filed sales totalling more than $12 million this week. CEO Gayn Erickson led the…
